Solid forms of enantiopure deuterium-enriched bupropion and methods of use thereof
US12180137B1 · kind B1 · utility
0Cited by
4References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 1, 2024 |
| Grant date | Dec 31, 2024 |
| Priority date | — |
| Expiry date | May 1, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides a crystalline form of enantiopure deuterium-enriched bupropion, pharmaceutical compositions, and methods of treating mood disorders, neurological disorders, movement disorders, cardiovascular disorders, metabolic disorders, and other disorders using a crystalline form of enantiopure deuterium-enriched bupropion.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.